The class of 3-{4-(5-mercapto-1,3,4-oxadiazole-2-yl) phenylimino} indolin-2-one is still not very well understood. This category shows potential in several classes of drugs. We have exploited the nucleus for potential anticancer agents. As anticancer drugs on the various site of the cell cycle, interfering with DNA structure, inhibiting cell wall etc. but basically it should bind to the site of DNA molecule to get the promising anticancer activity. We have undertaken the molecular docking study of isatin derivatives so as to explore this moiety and get novel anticancer agents. Molecular docking study gives binding sites, molecular interpretation and structural analysis of the compound that will help us to design new promising set of compounds which will help to design novel anticancer agents.
Loading....